Loading...
•
Dec 31, 2020
Health Catalyst Q4 2020 Earnings Report
Achieved strong performance with revenue exceeding guidance midpoint.
Key Takeaways
Health Catalyst reported strong Q4 2020 results, exceeding the midpoint of quarterly and full-year guidance for both revenue and Adjusted EBITDA. The company's technology played a key role in supporting customers' pandemic response.
Achieved strong performance across the business in Q4 2020.
Exceeded the mid-point of quarterly and full-year guidance for both revenue and Adjusted EBITDA.
Data and analytics technology played a key role in enabling customers’ response to the pandemic.
Chargemaster Management product was ranked as Best in KLAS for 2020.
Health Catalyst
Health Catalyst
Health Catalyst Revenue by Segment
Revenue by Segment
Technology Revenue
CapyFin.comProfessional Services Revenue
CapyFin.com Forward Guidance
For the first quarter of 2021, Health Catalyst expects total revenue between $53.0 million and $56.0 million, and Adjusted EBITDA between $(3.9) million and $(1.9) million. For the full year of 2021, the company expects total revenue between $225.1 million and $228.1 million, and Adjusted EBITDA between $(16.0) million and $(13.5) million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income